MORNING NEWS

Estrategia de mercado de los analistas de Swissquote

Anthropic to Pay Akamai Technologies $11.6 Billion for Cloud Services

Por Stefano GIANTI
Sep 25, 2026
Anthropic will pay Akamai Technologies AKAM at least $11.6 billion to use its cloud infrastructure and software for over seven years in an expansion of the partnership between the two companies.

OpenAI Agent Hacked Australian Government Website

Por Stefano GIANTI
Sep 24, 2026
An OpenAI agent infiltrated a government-services website in Australia this summer, Prime Minister Anthony Albanese said Wednesday at the United Nations meeting in New York.

Meta’s New AI Agent Is an Instant Hit—and the Backlash Has Already Begun

Por Stefano GIANTI
Sep 23, 2026
Meta Platforms (-0.6%) appears to have a hit AI product on its hands, but the company’s path to ultimate domination in this next chapter of consumer AI use is anything but assured. Two weeks ago, Meta launched a new, easy-to-use personal AI agent called Muse. The app, which is how users access the agent, has been sitting at No. 1 on Apple’s U.S.

Roche's Eye Drug Susvimo Obtains EU Approval

Por Igor JOVICIC
Sep 22, 2026
Roche will be able to market its eye medication Susvimo in the European Union. As the Swiss pharmaceutical company announced, the European Commission has granted approval. Susvimo is a treatment for neovascular age-related macular degeneration.

UBS CEO Ermotti Calls Capital Compromise “Manageable”

Por Stefano GIANTI
Sep 21, 2026
UBS CEO Sergio Ermotti sharply criticized the authorities ahead of the ‚Swiss Council of States’ decision on UBS regulation.

Yeti Sees Long-Term Growth Driven by New Product Lines, International Expansion

Por Stefano GIANTI
Sep 18, 2026
YETI Holdings expects its growth to continue in the years ahead as it looks to expand its product portfolio and international presence.

IBM Seals $1 Billion Government Deal to Build America’s First Quantum Foundry

Por Stefano GIANTI
Sep 17, 2026
Shares of International Business Machines IBM spiked in May after the legacy tech giant unveiled an agreement with the U.S. government to build a standalone quantum chip foundry. On Wednesday, that industry first became a reality. Anderon, an IBM company, announced the finalization of a $1 billion award from the Commerce Department, structured as a research-and-development grant under the 2022 Chips and Science Act.

Glencore disputes claims made against it by Radiant World

Por Igor JOVICIC
Sep 16, 2026
Glencore has ceased business dealings with the struggling Singapore-based iron ore trader Radiant World, as well as with Sapphire Minmetals and other associated companies. The Zug-based commodities giant, which is contesting “substantial claims” made against it by Radiant World and Minmetals, stated on Tuesday that it has evidence that the latter sent falsified invoices and contracts, as well as fraudulent emails, to financial institutions. Radiant World and Minmetals falsely claimed that the emails originated from Glencore employees, the Baar-based group said on Tuesday. Glencore is currently reviewing its business dealings with these companies.

Abbott Agrees to $385 Million Settlement in Baby Formula Case

Por Igor JOVICIC
Sep 15, 2026
Abbott Laboratories has agreed to pay $385 million to settle allegations related to its management of a baby formula facility where deadly bacteria was suspected of causing infant deaths, the Justice Department said Monday. The settlement is a more lenient outcome than some prosecutors had advocated for, believing they had evidence to criminally charge Abbott under a law that has been used to pursue other businesses for selling contaminated foods, the Journal previously reported.

Kroger Cuts Sales View, Citing Cyclospora and Pressured Shoppers

Por Stefano GIANTI
Sep 14, 2026
Kroger lowered its full-year same-store sales outlook, as shoppers’ budget constraints and concerns about cyclospora resulted in lower spending.
Switzerland

Diseñado con pasión en Suiza

Ser consciente del riesgo

El trading de productos apalancados en la plataforma Forex, como divisas, metales preciosos al contado y contratos por diferencia (CFDs), es altamente especulativo. Conlleva un nivel de riesgo de pérdida significativo debido al apalancamiento y puede no ser adecuado para todos los inversores. Antes de abrir una cuenta en Swissquote, considere su nivel de experiencia, sus objetivos de inversión, ingresos y propensión al riesgo. La operativa relativa a estos instrumentos pueden conllevar pérdidas teoréticamente ilimitadas y cabe la posibilidad que tenga que realizar depósitos adicionales si el saldo de su cuenta cae por debajo del nivel de margen requerido. Por lo tanto, no debe especular, invertir o cubrir el margen de su cuenta con capital que no esté dispuesto a perder y/o que le hayan prestado y/o que necesite urgentemente y/o que sea necesario para su subsistencia personal o familiar. En los últimos 12 meses, el 68.22% de los inversores minoristas ha perdido dinero al operar con Forex/CFDs o ha sufrido una pérdida total de su margen o ha acabado con un saldo negativo después de cerrar su posición. Debe ser consciente de todos los riesgos asociados con el trading de divisas/CFDs y, de ser necesario, solicitar el asesoramiento de un asesor financiero independiente si tiene alguna duda. Si desea obtener más detalles, incluida información sobre el efecto de apalancamiento, el funcionamiento de los márgenes y los riesgos de contraparte y de mercado, le invitamos a que consulte nuestra Declaración (aviso) sobre los Riesgos Relacionados con Forex y CFDs. El contenido de este sitio web representa material publicitario y no ha sido presentado a ni aprobado por ninguna autoridad supervisora.

Contenido generado con IA

Algunas de las imágenes de nuestro sitio web se han generado y/o retocado con aplicaciones de inteligencia artificial (IA). Sin embargo, todo el contenido está sujeto a la revisión y aprobación humanas para garantizar su exactitud, pertinencia y adecuación con las necesidades de nuestros usuarios y clientes.